U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Vaccine
  • Personal Author:
  • Description:
    Background:

    Since the last review of vaccine safety surveillance data for erythema multiforme (EM), Stevens Johnson syndrome (SJS), SJS/TEN, and toxic epidermal necrolysis (TEN) (EM/SJS/TEN), over 37 new vaccines have been introduced in the United States. We sought to describe reported EM/SJS/TEN after vaccines during 1999–2017.

    Methods:

    We identified U.S. reports of EM/SJS/TEN received by the Vaccine Adverse Event Reporting System (VAERS) during 1999–2017. We stratified analysis by condition (EM, SJS, or TEN), and analyzed reports by serious or non-serious status, sex, age group, time from vaccination to symptom onset, exposure to known causes of EM/SJS/TEN, and vaccines administered. We used Empirical Bayesian data mining to detect vaccine-AE pairs reported more frequently than expected.

    Results:

    Of 466,027 reports to VAERS during 1999–2017, we identified 984 reports of EM, 89 reports of SJS, 6 reports of SJS/TEN, and 7 reports of TEN. Few reports of EM (9%), and most reports of SJS (52%), SJS/TEN (100%), and TEN (100%) were serious. Overall, 55% of reports described males, 48% described children aged < 4 years; 58% of EM/SJS/TEN occurred ≤ 7 days after vaccination. Few reports (≤5%) described exposure to known causes of EM/SJS/TEN. Overall, childhood vaccines (e.g., combined measles, mumps, and rubella vaccine) were most commonly reported. We identified 6 deaths; 4 were exposed to medications associated with EM/SJS/TEN. EM after smallpox vaccine was reported disproportionately among people aged 19–49 years.

    Conclusions:

    EM/SJS/TEN were rarely reported after vaccination; data mining identified a known association between EM and smallpox vaccine.

  • Subjects:
  • Keywords:
  • Source:
    Vaccine. 38(7):1746-1752
  • Pubmed ID:
    31870573
  • Pubmed Central ID:
    PMC7008074
  • Document Type:
  • Funding:
  • Volume:
    38
  • Issue:
    7
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:2b7b9a7d8278735ae4cac700a53e4d33fc3caec082e214837bd9a3e1c44d20cdff5088726672fbd1f8387c3ea8585ba2f7168ecd530a8b43ce7389c61d39aae7
  • Download URL:
  • File Type:
    Filetype[PDF - 97.47 KB ]
File Language:
English
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.